KSE Peer Comparison
NSE: KSE | BSE: 519421
₹176.80
As on 09-Nov-2026 09:09IST
Market cap
₹557 Cr
Revenue (TTM)
₹1,718 Cr
P/E Ratio
12
P/B Ratio
1.6
Div. Yield
7.2 %
| KSE | Godrej Agrovet | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
557 | 11,635 | 89 | 54 | 49 |
Revenue (₹ Cr) |
1,718 | 10,901 | 98 | 213 | 1 |
Net Profit (₹ Cr) |
46.43 | 400.49 | 3.13 | 4.66 | -0.09 |
Net Margin (%) |
2.68 | 3.63 | 3.15 | 2.18 | -9.45 |
RoE (%) |
13.15 | 24.08 | 5.20 | 5.10 | -0.35 |
Price to Earnings |
11.99 | 24.79 | 28.47 | 11.51 | -- |
Price-To-Book |
1.59 | 5.60 | 1.46 | 0.56 | 1.61 |
Income Statement (₹ Cr)
| KSE | Godrej Agrovet | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Operating Revenue
|
1,718.16 | 10,901.17 | 98.12 | 212.73 | 0.54 |
|
Total Income
|
1,732.44 | 11,023.92 | 99.32 | 213.79 | 0.90 |
|
Total Expenditure
|
1,658.60 | 10,080.79 | 94.07 | 203.49 | 0.86 |
|
EBITDA
|
59.55 | 820.38 | 4.05 | 9.24 | -0.33 |
|
Depreciation
|
8.30 | 228.33 | 0.22 | 2.68 | 0.00 |
|
EBIT
|
51.26 | 592.05 | 3.83 | 6.56 | -0.33 |
|
Interest
|
2.62 | 126.12 | 0.75 | 1.02 | 0.00 |
|
Other Income
|
14.29 | 122.75 | 1.20 | 1.06 | 0.36 |
|
Exceptional Items
|
0.47 | -30.44 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
63.40 | 558.24 | 4.28 | 6.60 | 0.03 |
|
Provision for Tax
|
16.97 | 157.75 | 1.15 | 1.94 | 0.12 |
|
Profit after Tax
|
46.43 | 400.49 | 3.13 | 4.66 | -0.09 |
Liabilities (₹ Cr)
| KSE | Godrej Agrovet | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
349.50 | 2,075.88 | 61.07 | 91.62 | 33.08 |
|
Minority Interest
|
0.00 | 26.31 | 0.00 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
23.95 | 577.23 | 0.77 | 1.71 | 0.00 |
|
Current Liabilities
|
41.53 | 3,654.87 | 12.77 | 31.57 | 0.21 |
|
Total Liabilities
|
414.98 | 6,160.85 | 72.25 | 120.37 | 15.61 |
Assets (₹ Cr)
| KSE | Godrej Agrovet | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
62.88 | 2,899.41 | 12.02 | 32.71 | 0.15 |
|
Current Assets
|
349.72 | 3,022.63 | 62.02 | 74.47 | 33.14 |
|
Total Assets
|
414.98 | 6,160.85 | 72.25 | 120.37 | 15.61 |
|
Total Debt*
|
24.87 | 1,468.43 | 10.10 | 17.76 | 0.00 |
|
Net Current Assets
|
308.19 | -632.24 | 49.25 | 42.90 | 32.93 |
|
Contingent Liabilities
|
1.86 | 164.76 | 0.05 | -- | -- |
Cashflow (₹ Cr)
| KSE | Godrej Agrovet | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
53.52 | 1,281.17 | -1.30 | -5.73 | 0.00 |
|
Cash Flow from Investing Activities
|
-8.92 | -150.39 | -2.95 | -15.77 | -- |
|
Cash from Financing Activities
|
-33.22 | -868.90 | -0.18 | 15.09 | 0.00 |
|
Net Cash Inflow / Outflow
|
11.38 | 261.88 | -4.43 | -6.41 | 0.00 |
Ratios
Profitability Ratios
| KSE | Godrej Agrovet | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
ROCE (%)
|
33.62 | 20.95 | 8.94 | 6.53 | 2.84 |
|
ROE (%)
|
13.15 | 24.08 | 5.20 | 5.10 | -0.35 |
|
ROA (%)
|
12.03 | 6.39 | 4.31 | 4.15 | -0.51 |
|
EBIT Margin (%)
|
2.98 | 5.43 | 3.90 | 3.09 | -61.27 |
|
Net Margin (%)
|
2.68 | 3.63 | 3.15 | 2.18 | -9.45 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| KSE | Godrej Agrovet | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
5.14 | 11.64 | 48.29 | 76.83 | -77.37 |
|
EBIT Growth (%)
|
-62.97 | -4.77 | -11.20 | 181.11 | -159.49 |
|
Net Profit Growth (%)
|
-58.35 | 11.14 | -18.10 | 27.00 | -114.03 |
|
EPS Growth (%)
|
-95.80 | 13.56 | -25.49 | 27.00 | -129.45 |
|
Book Value Growth (%)
|
17.78 | -14.87 | 6.21 | 3.69 | 2.11 |
Valuation Ratios
| KSE | Godrej Agrovet | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Price / Earnings
|
12.18 | 23.83 | 15.76 | 11.05 | -118.92 |
|
Price / Book Value
|
1.60 | 5.68 | 1.47 | 0.58 | 1.55 |
|
Dividend Yield (%)
|
7.13 | 1.80 | 0.00 | 0.00 | 0.00 |
|
EV/EBITDA
|
6.66 | 15.78 | 22.11 | 7.74 | -145.87 |
|
Market Cap (₹ Cr)
|
564.14 | 10,276.68 | 115.67 | 66.15 | 15.29 |
Solvency Ratios
| KSE | Godrej Agrovet | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.05 | 0.16 | 0.01 | 0.02 | 0.00 |
|
Short term debt to equity ratio
|
0.00 | 0.19 | 0.15 | 0.18 | -- |
|
Current Ratio
|
8.42 | 0.83 | 4.86 | 2.36 | 157.07 |
|
Quick Ratio
|
4.97 | 0.33 | 3.89 | 1.03 | 124.98 |
|
Interest Coverage
|
25.24 | 5.43 | 6.73 | 7.47 | 131.18 |
Operating Efficiency Ratios
| KSE | Godrej Agrovet | Narmada Agrobase | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
0.06 | 6.86 | 37.78 | 7.78 | 730.91 |
|
Asset Turnover
|
4.45 | 1.74 | 1.35 | 1.89 | 0.03 |
|
Receivable days
|
0.29 | 21.15 | 126.71 | 34.07 | 561.48 |
|
Inventory Days
|
27.72 | 44.46 | 87.41 | 63.48 | 1,011.41 |
|
Payable days
|
2.46 | 31.76 | 3.90 | 15.31 | 28.80 |
|
Cash Conversion Cycle
|
25.54 | 33.86 | 210.22 | 82.25 | 1,544.08 |